Company

Mycenax Biotech, Inc.

Headquarters: Miaoli, Taiwan

Employees: 257

TWSE: 4726 -1.98%

Market Cap

TW$11.77 Billion

TWD as of July 1, 2024

US$361.5 Million

Market Cap History

Mycenax Biotech, Inc. market capitalization over time

Evolution of Mycenax Biotech, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Mycenax Biotech, Inc.

Detailed Description

Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian and microbial cell lines in Taiwan, Europe, and the United States. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), as well as plasmids and DNA vaccines. It also provides process development solutions, including development of production cell lines, upstream and downstream process development, process scale-up, formulation development, and analytical methods; in-house analytical services; GMP manufacturing services, such as drug substance and products manufacturing, and cell banking; and manufacturing technologies. The company was founded in 2001 and is headquartered in Zhubei City, Taiwan.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Mycenax Biotech, Inc. has the following listings and related stock indices.


Stock: TWSE: 4726 wb_incandescent

Details

Headquarters:

No.50-7, Keyan Road

4th Floor Jhunan

Miaoli, 35053

Taiwan

Phone: 886 37 586 988

Fax: 886 37 586 188